Navigation Links
Reportlinker Adds Bioinformatics and Computational Biology: Bottlenecks and Options
Date:10/26/2009

NEW YORK, Oct. 26 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Reportlinker Adds Bioinformatics and Computational Biology: Bottlenecks and Options

http://www.reportlinker.com/p0156561/Reportlinker-Adds-Bioinformatics-and-Computational-Biology-Bottlenecks-and-Options.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

The interdisciplinary fields of Bioinformatics and Computational Biology are locked in a high stakes race with analytical instrument developers and innovators. The pace and scope of change in many fields of biomedical research rivals what we once associated only with semiconductor devices. This report explores the interlocking challenges facing instrumentation advances, computational demands and our evolving systems biology knowledge. Key challenges presented in this report include:

  • Instrumentation capable of generating terabytes of raw data daily
  • Storage requirements for human gene sequences
  • Need for cross platform data analysis standards
  • Appropriateness of analysis & modeling applications
  • Database data quality and annotation protocols

Bioinformatics and Computational Biology: Bottlenecks and Options reviews the state of the art and aims to determine the significant technological and market trends in the application of informatics and computation techniques to biological research and drug discovery. The progress of molecular biology has given us a profound understanding of human physiology and pathology at a molecular level. However, we understand that a functioning organism is more than simply a sum of chemical reactions. In recent years a concerted effort has been directed at moving from a reductionist approach to understanding physiology in an integrative systems framework complete with the associated mathematical-based models.

The growth of systems biology has been aided by the availability of constantly evolving computational capacity of cheap hardware as well as advances in analytical research instruments capable in some applications of generating terabytes of data each day. Such instruments are being used to make time series measurements of multiple-analyte fluxes during the perturbation of a physiological system. The robustness of such data are the building blocks for computational biology.

This report describes the tension the combined fields of Bioinformatics and Computational Biology are experiencing by first reviewing the capabilities of innovative analytical instrumentation to generate terabytes of data and then considering the availability of approaches, both in software and hardware, to compress, store, retrieve and combine these data. The report identifies this supply and demand as a strategic bottleneck issue. The discussion also considers issues of cross platform data analysis standards and the appropriate use of analysis and modeling applications on data quality.

Bioinformatics and Computational Biology: Bottlenecks and Options presents an analysis of the state of the field in terms of the current systems biology models and their applications, where the field is headed and the possible implications for applied biological science. The report also includes profiles of systems biology vendors and their products as well as a discussion of the applications in areas such as personalized medicine and drug discovery. The report closes with an overview of the strategy pressure points and the interlocking challenges inherent with instrumentation advances, computational demands and our evolving systems biology knowledge.

Chapter One INTRODUCTION TO BIOINFORMATICS AND COMPUTATIONAL BIOLOGY

1.1. Definitions; Principle and Applications

To order this report:

Reportlinker Adds Bioinformatics and Computational Biology: Bottlenecks and Options

http://www.reportlinker.com/p0156561/Reportlinker-Adds-Bioinformatics-and-Computational-Biology-Bottlenecks-and-Options.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

More market research reports here!

    CONTACT:
    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Global Top 10 Biotechnology Companies -- Industry, Financial and SWOT Analysis
2. Reportlinker Adds Stem Cell Therapeutics Markets Report
3. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
4. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
5. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
6. Reportlinker Adds Membrane Bioreactors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Small Molecule Kinase Inhibitors Report
9. Reportlinker Adds Nanomedicine Report
10. Reportlinker Adds Proteomics: Technologies and Global Markets Report
11. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers can fast-track sample ... acid, and/or other biomarkers or SNPs of interest) using one, easy-to-collect saliva sample. ... the relationship between insulin and other relevant biomarkers can be extensively studied through ...
(Date:2/23/2017)... LOS ANGELES , Feb. 23, 2017  Capricor Therapeutics, ... cardiac and other medical conditions, today announced that Linda Marbán, ... at two upcoming investor conferences: Cowen ... 2017 at 10:00 am ET Boston, MA ... 14, 2017 at 9:00 am PT (12:00 pm ET) ...
(Date:2/23/2017)... DIEGO and SAN FRANCISCO ... a privately-held regenerative medicine company, and Beyond Type 1, ... with type 1 diabetes, today announced a grant from ... a functional cure for type 1 and other insulin-requiring ... ViaCyte has been developing innovative stem cell-derived cell replacement ...
(Date:2/22/2017)... 2017  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics ... biopharmaceutical products for companion animals, will host a live conference ... to discuss financial results from the fourth quarter and full ... and investors may access the audio webcast or ... ...
Breaking Biology Technology:
(Date:2/8/2017)... Feb. 7, 2017 The biometrics market ... the confluence of organizations, desires to better authenticate ... systems (password and challenge questions), biometrics is quickly ... systems. The market is driven by use cases, ... consumer and enterprise uses cases, with consumer-facing use ...
(Date:2/7/2017)... 7, 2017   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... innovative, highly flexible and award winning eClinical solution, is ... iMedNet is a proven Software-as-a-Service (SaaS) clinical research ... (EDC), but also delivers an entire suite of eClinical ...
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
Breaking Biology News(10 mins):